Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth McIntosh

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Plos Clinical Trials|May 4, 2007
Haematological safety of perinatal zidovudine in pregnant HIV-1-infected women in Thailand: secondary analysis of a randomized trialNelly Briand, Marc Lallemant, Gonzague Jourdain, et al.
The Journal of Infectious Diseases|November 17, 2007
Risk factors for in utero or intrapartum mother-to-child transmission of human immunodeficiency virus type 1 in ThailandGonzague Jourdain, Jean-Yves Mary, Sophie Le Coeur, et al.
The New England Journal of Medicine|July 13, 2004
Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in ThailandMarc Lallemant, Gonzague Jourdain, Sophie Le Coeur, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 1, 2009
Early immunological predictors of neurodevelopmental outcomes in HIV-infected childrenJutarat Mekmullica, Pim Brouwers, Manhattan Charurat, et al.
The Journal of Infectious Diseases|June 18, 2005
Immune reconstitution after receipt of highly active antiretroviral therapy in children with advanced or progressive HIV disease and complete or partial viral load responseAndrea Kovacs, Grace Montepiedra, Vincent Carey, et al.
The Journal of Allergy and Clinical Immunology|April 5, 2005
Predictors of immunologic long-term nonprogression in HIV-infected children: implications for initiating therapyMary E Paul, Charlotte Mao, Manhattan Charurat, et al.
The Pediatric Infectious Disease Journal|March 29, 2006
Growth of human immunodeficiency virus-uninfected children exposed to perinatal zidovudine for the prevention of mother-to-child human immunodeficiency virus transmissionNelly Briand, Sophie Le Coeur, Patrinee Traisathit, et al.
The Journal of Infectious Diseases|September 23, 2006
Effect of perinatal antiretroviral drug exposure on hematologic values in HIV-uninfected children: An analysis of the women and infants transmission studySusan E Pacheco, Kenneth McIntosh, Ming Lu, et al.
Pediatrics|March 3, 2006
A behavioral and cognitive profile of clinically stable HIV-infected childrenMolly L Nozyce, Sophia S Lee, Andrew Wiznia, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 6, 2002
Association of HIV-1 viral phenotype in the MT-2 assay with perinatal HIV transmissionPhilip LaRussa, Laurence S Magder, Jane Pitt, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Plos Clinical Trials|May 4, 2007
Haematological safety of perinatal zidovudine in pregnant HIV-1-infected women in Thailand: secondary analysis of a randomized trialNelly Briand, Marc Lallemant, Gonzague Jourdain, et al.
The Journal of Infectious Diseases|November 17, 2007
Risk factors for in utero or intrapartum mother-to-child transmission of human immunodeficiency virus type 1 in ThailandGonzague Jourdain, Jean-Yves Mary, Sophie Le Coeur, et al.
The New England Journal of Medicine|July 13, 2004
Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in ThailandMarc Lallemant, Gonzague Jourdain, Sophie Le Coeur, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 1, 2009
Early immunological predictors of neurodevelopmental outcomes in HIV-infected childrenJutarat Mekmullica, Pim Brouwers, Manhattan Charurat, et al.
The Journal of Infectious Diseases|June 18, 2005
Immune reconstitution after receipt of highly active antiretroviral therapy in children with advanced or progressive HIV disease and complete or partial viral load responseAndrea Kovacs, Grace Montepiedra, Vincent Carey, et al.
The Journal of Allergy and Clinical Immunology|April 5, 2005
Predictors of immunologic long-term nonprogression in HIV-infected children: implications for initiating therapyMary E Paul, Charlotte Mao, Manhattan Charurat, et al.
The Pediatric Infectious Disease Journal|March 29, 2006
Growth of human immunodeficiency virus-uninfected children exposed to perinatal zidovudine for the prevention of mother-to-child human immunodeficiency virus transmissionNelly Briand, Sophie Le Coeur, Patrinee Traisathit, et al.
The Journal of Infectious Diseases|September 23, 2006
Effect of perinatal antiretroviral drug exposure on hematologic values in HIV-uninfected children: An analysis of the women and infants transmission studySusan E Pacheco, Kenneth McIntosh, Ming Lu, et al.
Pediatrics|March 3, 2006
A behavioral and cognitive profile of clinically stable HIV-infected childrenMolly L Nozyce, Sophia S Lee, Andrew Wiznia, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 6, 2002
Association of HIV-1 viral phenotype in the MT-2 assay with perinatal HIV transmissionPhilip LaRussa, Laurence S Magder, Jane Pitt, et al.
Pageof 7